Advertisement
Advertisement
ELAN
Elanco Animal Health Incorporated Common Stock
22.12
USDSponsored
-2.08
-8.60%
Aug 07, 15:59 UTC -4
Closed
After-Market
22.33
+0.21
+0.95%
ELAN Earnings Reports
Positive Surprise Ratio
ELAN beat 27 of 32 last estimates.
84%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.22B
/$0.20
Implied change from Q2 26 (Revenue/ EPS)
-11.13%
/-41.18%
Implied change from Q3 25 (Revenue/ EPS)
+6.93%
/+5.26%
Elanco Animal Health Incorporated Common Stock earnings per share and revenue
On Aug 05, 2026, ELAN reported earnings of 0.34 USD per share (EPS) for Q2 26, beating the estimate of 0.27 USD, resulting in a 23.77% surprise. Revenue reached 1.37 billion, compared to an expected 1.34 billion, with a 2.18% difference. The market reacted with a +2.42% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of 0.20 USD, with revenue projected to reach 1.22 billion USD, implying an decrease of -41.18% EPS, and decrease of -11.13% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DaVita Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
$3.92
Actual
$4.01
Surprise
+2.52%
Encompass Health Corporation Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$1.49
Actual
$1.55
Surprise
+3.56%
Chemed Corporation
Report Date
Jul 28, 2026 For Q2 26
Estimate
$5.65
Actual
$6.06
Surprise
+7.14%
LifeStance Health Group, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.04
Actual
$0.06
Surprise
+34.53%
Option Care Health, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.43
Actual
$0.45
Surprise
+3.16%
Addus HomeCare Corp.
Report Date
Aug 03, 2026 For Q2 26
Estimate
$1.73
Actual
$1.73
Surprise
-0.18%
Astrana Health Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.34
Actual
$0.40
Surprise
+16.58%
The Pennant Group, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.33
Actual
$0.36
Surprise
+6.95%
US Physical Therapy Inc
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.86
Actual
$0.75
Surprise
-12.81%
FAQ
What were Elanco Animal Health Incorporated Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Elanco Animal Health Incorporated Common Stock reported EPS of $0.34, beating estimates by 23.77%, and revenue of $1.37B, 2.18% above expectations.
How did the market react to Elanco Animal Health Incorporated Common Stock's Q2 2026 earnings?
The stock price moved up 2.42%, changed from $25.60 before the earnings release to $26.22 the day after.
When is Elanco Animal Health Incorporated Common Stock expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Elanco Animal Health Incorporated Common Stock's next earnings report?
Based on 13
analysts, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.20 and revenue of $1.22B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement